Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology | Hematology
Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An International Multicenter, Open Label Study of Vorinostat (MK-0683) in Combination with Bortezomib in Patients with Relapsed and Refractory Multiple Myeloma
CIBMTR: 07-REV; Evaluation of Lenalidomide as Maintenance Therapy Post Allogenic Hematopoietic Cell Transplantation for High Risk Multiple Myeloma
Correlating Organ Dose and Dose-Volume with Toxicities After Total Marrow Irradiation (TMI) Using Helical Tomotherapy in Patients with Multiple Myeloma Undergoing Hematopoetic Cell Transplantation (HCT)
Tandem High-Dose Therapy with Melphalan and Total Marrow Irradiation (TMI) with Peripheral Blood Progenitor Cell Support and Dexamethasone and Thalidomide Maintenance in Multiple Myeloma: A Phase I/II Trial
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Multiple Myeloma Study CLBH589B2206
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
This study will test the ability of a specially designed antibody to target and destroy multiple myeloma cells.
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Multiple Myeloma Study CLBH589B2207
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Multiple Myeloma Study CLBH589B2206
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
This study will test the ability of a specially designed antibody to target and destroy multiple myeloma cells.
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Safety, Efficacy, Dose-Finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Multiple Myeloma Study CLBH589B2207
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
This study will test the ability of a specially designed antibody to target and destroy multiple myeloma cells.
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Relapsed or Refractory Multiple Myeloma - Adults
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Multiple Myeloma Study CLBH589B2206
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
This study will test the ability of a specially designed antibody to target and destroy multiple myeloma cells.
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Phase II Study Of Antineoplatons A10 And AS2-1 In Patients With Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
An Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma
A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
COMPARE Study: A Study to Compare the Renal Safety of Bondronat (Ibandronate) and Zoledronate in Patients With Multiple Myeloma
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
UPFRONT™ - a clinical trial for patients with newly diagnosed Multiple Myelomas
